These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 9038377)
1. Distinct signaling pathways regulate transformation and inhibition of skeletal muscle differentiation by oncogenic Ras. Weyman CM; Ramocki MB; Taparowsky EJ; Wolfman A Oncogene; 1997 Feb; 14(6):697-704. PubMed ID: 9038377 [TBL] [Abstract][Full Text] [Related]
2. Oncogenic Ras-induced secretion of a novel inhibitor of skeletal myoblast differentiation. Weyman CM; Wolfman A Oncogene; 1997 Nov; 15(21):2521-8. PubMed ID: 9399640 [TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinase kinase (MEK) activity is required for inhibition of skeletal muscle differentiation by insulin-like growth factor 1 or fibroblast growth factor 2. Weyman CM; Wolfman A Endocrinology; 1998 Apr; 139(4):1794-800. PubMed ID: 9528964 [TBL] [Abstract][Full Text] [Related]
4. Active Ras-induced effects on skeletal myoblast differentiation and apoptosis are independent of constitutive PI3-kinase activity. Karasarides M; Dee K; Schulman D; Wolfman A; Weyman CM Cell Biol Int; 2006 Apr; 30(4):308-18. PubMed ID: 16503174 [TBL] [Abstract][Full Text] [Related]
5. Signaling through mitogen-activated protein kinase and Rac/Rho does not duplicate the effects of activated Ras on skeletal myogenesis. Ramocki MB; Johnson SE; White MA; Ashendel CL; Konieczny SF; Taparowsky EJ Mol Cell Biol; 1997 Jul; 17(7):3547-55. PubMed ID: 9199290 [TBL] [Abstract][Full Text] [Related]
6. Apoptosis coincident with the differentiation of skeletal myoblasts is delayed by caspase 3 inhibition and abrogated by MEK-independent constitutive Ras signaling. Dee K; Freer M; Mei Y; Weyman CM Cell Death Differ; 2002 Feb; 9(2):209-18. PubMed ID: 11840171 [TBL] [Abstract][Full Text] [Related]
7. Raf-1 activation stimulates proliferation and inhibits IGF-stimulated differentiation in L6A1 myoblasts. Samuel DS; Ewton DZ; Coolican SA; Petley TD; McWade FJ; Florini JR Horm Metab Res; 1999; 31(2-3):55-64. PubMed ID: 10226782 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of myogenesis by the H-ras oncogene: implication of a role for protein kinase C. Vaidya TB; Weyman CM; Teegarden D; Ashendel CL; Taparowsky EJ J Cell Biol; 1991 Aug; 114(4):809-20. PubMed ID: 1714463 [TBL] [Abstract][Full Text] [Related]
9. Raf-induced effects on the differentiation and apoptosis of skeletal myoblasts are determined by the level of Raf signaling: abrogation of apoptosis by Raf is downstream of caspase 3 activation. DeChant AK; Dee K; Weyman CM Oncogene; 2002 Aug; 21(34):5268-79. PubMed ID: 12149648 [TBL] [Abstract][Full Text] [Related]
10. Differential signaling through NFkappaB does not ameliorate skeletal myoblast apoptosis during differentiation. Dee K; DeChant A; Weyman CM FEBS Lett; 2003 Jun; 545(2-3):246-52. PubMed ID: 12804784 [TBL] [Abstract][Full Text] [Related]
11. Insulin restores differentiation of Ras-transformed C2C12 myoblasts by inducing NF-kappaB through an AKT/P70S6K/p38-MAPK pathway. Conejo R; de Alvaro C; Benito M; Cuadrado A; Lorenzo M Oncogene; 2002 May; 21(23):3739-53. PubMed ID: 12032842 [TBL] [Abstract][Full Text] [Related]
12. ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion. Jones NC; Fedorov YV; Rosenthal RS; Olwin BB J Cell Physiol; 2001 Jan; 186(1):104-15. PubMed ID: 11147804 [TBL] [Abstract][Full Text] [Related]
13. A role for RalGDS and a novel Ras effector in the Ras-mediated inhibition of skeletal myogenesis. Ramocki MB; White MA; Konieczny SF; Taparowsky EJ J Biol Chem; 1998 Jul; 273(28):17696-701. PubMed ID: 9651367 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of Ras signaling through NFkappaB on skeletal myogenesis. Mitin N; Kudla AJ; Konieczny SF; Taparowsky EJ Oncogene; 2001 Mar; 20(11):1276-86. PubMed ID: 11313872 [TBL] [Abstract][Full Text] [Related]
15. Contribution of Src and Ras pathways in FGF-2 induced endothelial cell differentiation. Klint P; Kanda S; Kloog Y; Claesson-Welsh L Oncogene; 1999 Jun; 18(22):3354-64. PubMed ID: 10362356 [TBL] [Abstract][Full Text] [Related]
16. Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells. Plattner R; Gupta S; Khosravi-Far R; Sato KY; Perucho M; Der CJ; Stanbridge EJ Oncogene; 1999 Mar; 18(10):1807-17. PubMed ID: 10086335 [TBL] [Abstract][Full Text] [Related]
17. Nuclear exclusion of forkhead box O and Elk1 and activation of nuclear factor-kappaB are required for C2C12-RasV12C40 myoblast differentiation. De Alvaro C; Nieto-Vazquez I; Rojas JM; Lorenzo M Endocrinology; 2008 Feb; 149(2):793-801. PubMed ID: 17962350 [TBL] [Abstract][Full Text] [Related]
18. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways. Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018 [TBL] [Abstract][Full Text] [Related]
19. Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation. Wilson EM; Tureckova J; Rotwein P Mol Biol Cell; 2004 Feb; 15(2):497-505. PubMed ID: 14595115 [TBL] [Abstract][Full Text] [Related]
20. The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk-1 phosphorylation from MAP kinase activation. Sugimoto T; Stewart S; Han M; Guan KL EMBO J; 1998 Mar; 17(6):1717-27. PubMed ID: 9501093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]